All In Biotech

Drug Trial Radar · NCT06748001

Avapritinib Rollover Study

An Open-label, Multicenter, Rollover Study in Patients Who Participated in an Avapritinib Clinical Study

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Nov 28, 2024

Primary completion

Dec 31, 2027

Study completion Dec 31, 2027

Sponsor

Sponsor type
Industry
First posted
Dec 24, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the rollover study is to evaluate the long-term safety of avapritinib in participants who have completed a Blueprint Medicines sponsored study (parent study) and continued to benefit from avapritinib.

Conditions

  • Mastocytosis, Systemic

Interventions

  • AvapritinibDrug

    Avapritinib will be administered in accordance with the parent study protocol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Serious Adverse Events (SAEs), Adverse Events of Special Interest (AESIs), and AEs leading to DiscontinuationTime frame: Up to approximately 4 years

Locations

10 sites in 9 countries. Site status is shown where the registry gives one.

  • Universitair Ziekenhuis Antwerpen (UZA)

    Edegem, Belgium · Recruiting

  • The Hospital for Sick Children

    Toronto, Ontario, Canada · Recruiting

  • Hôpital Pitié-Salpêtrière Charles Foix

    Paris, France · Recruiting

  • University Hospital Aachen

    Aachen, Germany · Recruiting

  • A.O.U. San Giovanni di Dio e Ruggi d'Aragona di Salerno

    Salerno, Italy · Recruiting

  • Universitair Medisch Centrum Groningen

    Groningen, Netherlands · Recruiting

  • Erasmus Medisch Centrum

    Rotterdam, Netherlands · Recruiting

  • Oslo University Hospital

    Oslo, Norway · Recruiting

  • Instituto de Estudios de Mastocitosis de Castilla la Mancha

    Toledo, Spain · Recruiting

  • Guys and St Thomas NHS Foundation Trust - St Thomas Hospital

    London, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.